Hormone therapy is a form of systemic therapy, meaning it reaches cancer cells almost anywhere in the body and not just in the breast. It's recommended for women with hormone receptor-positive (ER-positive and/or PR-positive) breast cancers, and it does not help women whose tumors are hormone receptor-negative (both ER- and PR-negative).
- Track 1-1 Reducing the risk of breast cancer
- Track 2-2 Anastrozole
- Track 3-3 Tamoxifen
- Track 4-4 Raloxifene